Interestingly, an opposite effect was observed in the hearts: the M1 marker decreased while the M2 markers (CD206, Arg1 and CD163) increased in TAC-operated, PyMT-bearing mice compared to non-tumor-bearing mice (Figure 4B–E). This evidence concerns the gene MRC1 and neoplasm.